ONCOVIN Drug Patent Profile

✉ Email this page to a colleague

When do Oncovin patents expire, and when can generic versions of Oncovin launch?

Oncovin is a drug marketed by Lilly and is included in one NDA.

The generic ingredient in ONCOVIN is vincristine sulfate. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the vincristine sulfate profile page.

Summary for ONCOVIN

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	42
Clinical Trials:	204
Patent Applications:	3,731
Formulation / Manufacturing:	see details
DailyMed Link:	ONCOVIN at DailyMed

Drug patent expirations by year for ONCOVIN

Recent Clinical Trials for ONCOVIN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Medical College of Wisconsin	Phase 1
Innovent Biologics (Suzhou) Co. Ltd.	Phase 2
Yazeed Sawalha	Phase 1

See all ONCOVIN clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for ONCOVIN

L01CA	Vinca alkaloids and analogues
L01C	PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
L01	ANTINEOPLASTIC AGENTS
L	Antineoplastic and immunomodulating agents

US Patents and Regulatory Information for ONCOVIN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lilly	ONCOVIN	vincristine sulfate	INJECTABLE;INJECTION	014103-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Lilly	ONCOVIN	vincristine sulfate	INJECTABLE;INJECTION	014103-003	Mar 7, 1984		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Lilly	ONCOVIN	vincristine sulfate	INJECTABLE;INJECTION	014103-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for ONCOVIN

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Lilly	ONCOVIN	vincristine sulfate	INJECTABLE;INJECTION	014103-003	Mar 7, 1984	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for ONCOVIN

See the table below for patents covering ONCOVIN around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Japan	H0244450		⤷ Try a Trial
Ireland	55388	STABLE PHARMACEUTICAL SOLUTIONS OF VINCA ALKALOIDS	⤷ Try a Trial
Hungary	191538	PROCESS FOR PRODUCING PHARMACEUTICAL COMPOSITIONS CONTAINING ACID ADDITIONAL SALTS OF VINCA-DIMERES	⤷ Try a Trial
Philippines	19098	READY TO USE FORMULATIONS FOR VINCA ALKALOIDS SELECTED FROM VINCRISTINE,VINBLASTINE AND VINDESINE	⤷ Try a Trial
United Kingdom	2125292	STABLE AQUEOUS FORMULATIONS OF VINCA ALKALOIDS	⤷ Try a Trial
Sweden	463804	EN ANVAENDNINGSKLAR FARMACEUTISK KOMPOSITION AV VINKADIMERASALTER	⤷ Try a Trial
New Zealand	204868	PHARMACEUTICAL COMPOSITIONS CONTAINING VINCA ALKALOIDS	⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Summary for ONCOVIN

Recent Clinical Trials for ONCOVIN

Anatomical Therapeutic Chemical (ATC) Classes for ONCOVIN

Make Better Decisions: Try a trial or see plans & pricing